Ethyl 5-oxo-1-phenyl-2-pyrazoline-3-carboxylate

We are Ethyl 5-oxo-1-phenyl-2-pyrazoline-3-carboxylate CAS:89-33-8 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Chemical Name: Ethyl 5-oxo-1-phenyl-2-pyrazoline-3-carboxylate
CAS.NO:89-33-8
Synonyms:3-Ethoxycarbonyl-1-phenyl-2-pyrazolin-5-one;PCEP (CarbethoxyPyrazolone);ethyl 1-phenylpyrazol-5-one-3-carboxylate;1-Phenyl-3-carboethoxy-5-pyrazolone;CEP
Molecular Formula:C12H12N2O3
Molecular Weight: 232.23500
 
Physical and Chemical Properties:
Density:1.25 g/cm3
Boiling point:335.3ºC at 760 mmHg
Melting point:252ºC (Decomposes)
Flash point:156.6ºC
Index of Refraction:1.594
 
Specification:
Appearance:Light yellow crystalline powder
Purity:≥99.0%
 
Packing: 25kg drum
Storage:This product should be sealed in a cool dry place.
Application:Mainly used for the organic synthesis of C.I. Pigment Red 38; 39; 42 varieties of coupling components.

Ethyl 5-oxo-1-phenyl-2-pyrazoline-3-carboxylate


Related News: “No two studies are the same, and each carries its own unique risks and presents individual challenges, but the aim of CTSuccess is to use the experience we have as a company in supplying materials for thousands of trials to identify the characteristics of a project upfront and highlight potential risk factors that may arise,” said Kristen Devito, Global Director, Catalent Clinical Supply Services.1-Bromo-2-iodobenzene The foundational patent, which expires in 2034, is owned by MSK and is licensed exclusively to Fate Therapeutics for all human therapeutic uses.2-etilhexil 4- (dimetilamino) benzoato CAS:21245-02-3 Optimize the reaction and improve the production process to reduce the production cost. At the same time, strengthen the determination and analysis of impurities to improve product quality.1228-53-1 Zhejiang Huahai Pharmaceutical: It is a leading company in domestic APIs, especially in the field of cardiovascular drugs.International Chemical Investors Group (ICIG) recently announced it has entered into a purchase agreement under which an affiliate of ICIG will acquire the pharmaceutical intermediates business from Genzyme Corporation.

Related Products
Product Name
3-(TRIFLUOROMETHOXY)ANISOLE View Details
3-chloro-p-toluidine View Details
9-Bromo-10-phenylanthracene View Details
2-Amino-5-chlorobenzotrifluoride manufacturer 4-Carbamonyl-N-Acetoacetanilide manufacturer 4-Bromo-N,N-dimethylaniline manufacturer Tetraoctylammonium bromide Cas:14866-33-2 manufacturer 1-Hydroxybenzotriazole manufacturer